Global BHK-21 Cells Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global BHK-21 Cells Market Insights, Forecast to 2034
The most widely used line is a subclone (clone 13) of BHK21, usually called as BHK 21(C13), which has been involved in the commercial manufacture of foot and mouth disease vaccines over a twenty year period. BHK-21 cells are susceptible to multiple viruses, including human adenovirus D, reovirus 3, vesicular stomatitis virus and so on.
Market Analysis and InsightsGlobal BHK-21 Cells Market
Global BHK-21 Cells market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, BHK-21 Cells industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
BHK-21 cells are a widely utilized cell line in the fields of cell culture and virus research. The market for these cells is substantial and has demonstrated steady sales performance. Specific uses include vaccine production, virus replication studies, and biopharmaceutical manufacturing. Future developments may involve further process optimization for enhanced production efficiency and quality, as well as exploring new applications in the emerging fields of cell therapy and regenerative medicine to address the growing market demands.
Report Covers
This report presents an overview of global BHK-21 Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global BHK-21 Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Creative Biolabs
ATCC
Merck
Procell Life Science&Technology
Obio Technology
WheLab
Nanjing Cobioer Biosciences
Boster Biological Technology
Segment by Type
With Culture Medium
Without Culture Medium
Life Science Research
Biopharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, BHK-21 Cells introduction, etc. BHK-21 Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of BHK-21 Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal BHK-21 Cells Market
Global BHK-21 Cells market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, BHK-21 Cells industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
BHK-21 cells are a widely utilized cell line in the fields of cell culture and virus research. The market for these cells is substantial and has demonstrated steady sales performance. Specific uses include vaccine production, virus replication studies, and biopharmaceutical manufacturing. Future developments may involve further process optimization for enhanced production efficiency and quality, as well as exploring new applications in the emerging fields of cell therapy and regenerative medicine to address the growing market demands.
Report Covers
This report presents an overview of global BHK-21 Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global BHK-21 Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Creative Biolabs
ATCC
Merck
Procell Life Science&Technology
Obio Technology
WheLab
Nanjing Cobioer Biosciences
Boster Biological Technology
Segment by Type
With Culture Medium
Without Culture Medium
Segment by Application
Life Science Research
Biopharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, BHK-21 Cells introduction, etc. BHK-21 Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of BHK-21 Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch